Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30276721)

  • 1. FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer.
    Harpain F; Ahmed MA; Hudec X; Timelthaler G; Jomrich G; Müllauer L; Selzer E; Dörr W; Bergmann M; Holzmann K; Grasl-Kraupp B; Grusch M; Berger W; Marian B; Silberhumer GR
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):77-86. PubMed ID: 30276721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ku70, Ku80, and sClusterin: A Cluster of Predicting Factors for Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer.
    Pucci S; Polidoro C; Joubert A; Mastrangeli F; Tolu B; Benassi M; Fiaschetti V; Greco L; Miceli R; Floris R; Novelli G; Orlandi A; Santoni R
    Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):381-388. PubMed ID: 28068245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer.
    Flanagan L; Kehoe J; Fay J; Bacon O; Lindner AU; Kay EW; Deasy J; McNamara DA; Prehn JH
    Radiat Oncol; 2015 Jun; 10():131. PubMed ID: 26071313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistance-associated protein 3 confers resistance to chemoradiotherapy for rectal cancer by regulating reactive oxygen species and caspase-3-dependent apoptotic pathway.
    Yu Z; Zhang C; Wang H; Xing J; Gong H; Yu E; Zhang W; Zhang X; Cao G; Fu C
    Cancer Lett; 2014 Oct; 353(2):182-93. PubMed ID: 25088576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Kim J; Ahn S; Kim K; Cho MS; Kim KH; Lee RA; Nam EM
    Anticancer Res; 2018 Dec; 38(12):6881-6889. PubMed ID: 30504405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
    Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc
    Wagner F; Hölig U; Wilczkowski F; Plesca I; Sommer U; Wehner R; Kießler M; Jarosch A; Flecke K; Arsova M; Tunger A; Bogner A; Reißfelder C; Weitz J; Schäkel K; Troost EGC; Krause M; Folprecht G; Bornhäuser M; Bachmann MP; Aust D; Baretton G; Schmitz M
    Front Immunol; 2019; 10():602. PubMed ID: 30984181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X-linked inhibitor of apoptosis protein is an independent prognostic marker for rectal adenocarcinoma after preoperative chemoradiotherapy.
    Chen YT; Tsao SC; Tsai HP; Wang JY; Chai CY
    Virchows Arch; 2016 May; 468(5):559-67. PubMed ID: 26915033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of ATP-binding cassette subfamily C member 4 increases sensitivity to neoadjuvant radiotherapy for locally advanced rectal carcinoma.
    Yu ZQ; Zhang C; Wang H; Lao XY; Chai R; Gao XH; Cao GW; Fu CG
    Dis Colon Rectum; 2013 May; 56(5):600-8. PubMed ID: 23575399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
    Li CF; He HL; Wang JY; Huang HY; Wu TF; Hsing CH; Lee SW; Lee HH; Fang JL; Huang WT; Chen SH
    J Clin Pathol; 2014 Dec; 67(12):1056-61. PubMed ID: 25271212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence and significance of preoperative intraarterial infusion chemotherapy combined with radiotherapy on survivin, p53 and Bax expression in low rectal carcinoma].
    Gan JL; Guo Y; Tang ZJ; Gao F; Tang WZ; Liu XJ
    Ai Zheng; 2006 Nov; 25(11):1423-7. PubMed ID: 17094914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
    Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor 4 induced resistance to radiation therapy in colorectal cancer.
    Ahmed MA; Selzer E; Dörr W; Jomrich G; Harpain F; Silberhumer GR; Müllauer L; Holzmann K; Grasl-Kraupp B; Grusch M; Berger W; Marian B
    Oncotarget; 2016 Oct; 7(43):69976-69990. PubMed ID: 27650548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.
    Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C
    Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy.
    Wu XY; Wu ZF; Cao QH; Chen C; Chen ZW; Xu Z; Li WS; Liu FK; Yao XQ; Li G
    World J Gastroenterol; 2014 Nov; 20(43):16268-74. PubMed ID: 25473182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines.
    Mott NN; Chung WC; Tsai PS; Pak TR
    PLoS One; 2010 Apr; 5(4):e10143. PubMed ID: 20405041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
    Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
    BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer.
    Maurer CA; Mattiello D; Duwe J; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
    Anticancer Res; 2012 May; 32(5):1721-8. PubMed ID: 22593452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy.
    Yu JI; Lee H; Park HC; Choi DH; Choi YL; Do IG; Kim HC; Lee WY; Yun SH; Cho YB; Huh JW; Park YA; Park YS; Park JO; Kim ST; Park W
    Oncotarget; 2016 Sep; 7(38):62676-62686. PubMed ID: 27391438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.